keyword
https://read.qxmd.com/read/38631030/evaluating-the-disease-related-experiences-of-tiktok-users-with-lupus-erythematosus-qualitative-and-content-analysis
#1
JOURNAL ARTICLE
Lindsey J Wanberg, David R Pearson
BACKGROUND: Lupus erythematosus (LE) is an autoimmune condition that is associated with significant detriments to quality of life and daily functioning. TikTok, a popular social networking platform for sharing short videos, provides a unique opportunity to understand experiences with LE within a nonclinical sample, a population that is understudied in LE research. This is the first qualitative study that explores LE experiences using the TikTok platform. OBJECTIVE: This study aims to evaluate the disease-related experiences of TikTok users with LE using qualitative and content analysis...
April 17, 2024: JMIR Infodemiology
https://read.qxmd.com/read/38625644/rare-combo-moyamoya-and-lupus-in-men
#2
REVIEW
Dilara Bulut Gökten, Murat Gökten, Çiğdem Deniz, Rıdvan Mercan
Moyamoya syndrome (MMS) is a rare, chronic, progressive cerebrovascular disorder characterized by stenosis at the apices of the intracranial internal carotid arteries, including the proximal anterior cerebral arteries and middle cerebral arteries. Cerebral angiography images are used for detection through measurement. Systemic lupus erythematosus (SLE) is an autoimmune disease that can cause multisystemic involvement. The coexistence of SLE and MMS has been rarely reported in the literature. A 46-year-old male patient with malar rash, Raynaud phenomenon presented to the hospital with a complaint of weakness in the left lower extremity, which began 3 days before the date of the visit...
April 16, 2024: Clinical Rheumatology
https://read.qxmd.com/read/38622515/systemic-lupus-erythematosus-combined-with-wilson-s-disease-a-case-report-and-literature-review
#3
REVIEW
Zhenle Yang, Qian Li, Suwen Liu, Zihan Zong, Lichun Yu, Shuzhen Sun
BACKGROUND: Systemic lupus erythematosus (SLE) and Wilson's disease (WD) are both systemic diseases that can affect multiple organs in the body. The coexistence of SLE and WD is rarely encountered in clinical practice, making it challenging to diagnose. CASE REPORT: We present the case of a 9-year-old girl who initially presented with proteinuria, haematuria, pancytopenia, hypocomplementemia, and positivity for multiple autoantibodies. She was diagnosed with SLE, and her blood biochemistry showed elevated liver enzymes at the time of diagnosis...
April 15, 2024: BMC Pediatrics
https://read.qxmd.com/read/38621786/extracellular-mitochondrial-components-as-new-biomarkers-for-lupus-nephritis
#4
JOURNAL ARTICLE
Sharath Gowda, Khushboo Rana, Ankit Kumar, Pradip Kumar Prajapati, Namisha Patel, Sapan Pandya, Ratika Srivastava
Major reason for mortality among systemic lupus erythematosus patients is renal failure due to the deposition of immune complexes in the glomeruli. Being a chronic disease with multiple relapses and remissions across the lifespan, it's important to know the degree of nephritis for diagnosis as well as the long-term clinical management of the patients. Currently, renal biopsy is being used as the gold standard to diagnose and define the stages of the disease. However, renal biopsy being invasive only provides a localized picture of nephritis, and has the risk of bleeding...
April 15, 2024: Lupus
https://read.qxmd.com/read/38619739/mendelian-causes-of-autoimmunity-the-lupus-phenotype
#5
REVIEW
Maud Tusseau, Samira Khaldi-Plassart, Jade Cognard, Sebastien Viel, Liliane Khoryati, Sarah Benezech, Anne-Laure Mathieu, Fréderic Rieux-Laucat, Brigitte Bader-Meunier, Alexandre Belot
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that is characterized by its large heterogeneity in terms of clinical presentation and severity. The pathophysiology of SLE involves an aberrant autoimmune response against various tissues, an excess of apoptotic bodies, and an overproduction of type-I interferon. The genetic contribution to the disease is supported by studies of monozygotic twins, familial clustering, and genome-wide association studies (GWAS) that have identified numerous risk loci...
April 15, 2024: Journal of Clinical Immunology
https://read.qxmd.com/read/38612414/emerging-molecular-and-synaptic-targets-for-the-management-of-chronic-pain-caused-by-systemic-lupus-erythematosus
#6
REVIEW
Han-Rong Weng
Patients with systemic lupus erythematosus (SLE) frequently experience chronic pain due to the limited effectiveness and safety profiles of current analgesics. Understanding the molecular and synaptic mechanisms underlying abnormal neuronal activation along the pain signaling pathway is essential for developing new analgesics to address SLE-induced chronic pain. Recent studies, including those conducted by our team and others using the SLE animal model ( MRL / lpr lupus-prone mice), have unveiled heightened excitability in nociceptive primary sensory neurons within the dorsal root ganglia and increased glutamatergic synaptic activity in spinal dorsal horn neurons, contributing to the development of chronic pain in mice with SLE...
March 22, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38611691/tumid-lupus-erythematosus-tle-a-review-of-a-rare-variant-of-chronic-cutaneous-lupus-erythematosus-ccle-with-emphasis-on-differential-diagnosis
#7
REVIEW
Maged Daruish, Francesca Ambrogio, Caterina Foti, Alessandra Filosa, Gerardo Cazzato
Tumid lupus erythematosus (TLE) has been the subject of heated debate regarding its correct nosographic classification. The definition of TLE has changed over time, varying according to the different studies performed. In this review, we address the initial definition of TLE, the changes that have taken place in the understanding of TLE, and its placement within the classification of cutaneous lupus erythematosus (CLE), with a focus on clinical, histopathological, immunophenotypical, and differential diagnosis aspects...
April 8, 2024: Diagnostics
https://read.qxmd.com/read/38609570/examination-of-the-shared-genetic-architecture-between-multiple-sclerosis-and-systemic-lupus-erythematosus-facilitates-discovery-of-novel-lupus-risk-loci
#8
JOURNAL ARTICLE
Sophia Kerns, Katherine A Owen, Dana Schwalbe, Amrie C Grammer, Peter E Lipsky
Systemic Lupus Erythematosus (SLE) is an autoimmune disease with heterogeneous manifestations, including neurological and psychiatric symptoms. Genetic association studies in SLE have been hampered by insufficient sample size and limited power compared to many other diseases. Multiple Sclerosis (MS) is a chronic relapsing autoimmune disease of the central nervous system (CNS) that also manifests neurological and immunological features. Here, we identify a method of leveraging large-scale genome wide association studies (GWAS) in MS to identify novel genetic risk loci in SLE...
April 12, 2024: Human Genetics
https://read.qxmd.com/read/38607271/idiopathic-intracranial-hypertension-as-the-initial-presenting-manifestation-of-systemic-lupus-erythematosus-in-a-child
#9
JOURNAL ARTICLE
Murugan Sudhakar, Anu P Kocheril, Anish S George, George I Vettiyil, Anitha Jasper, Sathish Kumar
Idiopathic intracranial hypertension (IIH) is a diagnosis of exclusion characterized by features of raised intracranial pressure (ICP) in the absence of brain parenchymal lesion, vascular malformations, hydrocephalus, or central nervous system (CNS) infection. Commonly used other terms for this entity include benign intracranial hypertension (BIH) or pseudotumor cerebri. Few case reports of systemic lupus erythematosus (SLE) presenting as IIH are available in the literature. We report a 12-year-old girl presented with chronic holocranial headache and occasional episodes of projectile vomiting for the last 6 months and then developed blurring of vision for the last month...
April 12, 2024: Lupus
https://read.qxmd.com/read/38597902/efficacy-of-anifrolumab-in-long-term-intractable-alopecia-due-to-discoid-lupus-erythematosus
#10
JOURNAL ARTICLE
Naoto Azuma, Masaru Natsuaki, Naoaki Hashimoto, Takeo Abe, Suzu Ueda, Yuko Ohno, Masatoshi Jinnin, Kiyoshi Matsui
Alopecia associated with lupus erythematosus is broadly classified into reversible nonscarring alopecia seen in the acute phase, such as worsening of systemic lupus erythematosus (SLE) and cicatricial alopecia seen in chronic cutaneous lupus erythematosus represented by discoid lupus erythematosus (DLE). In DLE-induced alopecia, early therapeutic intervention before developing scarring alopecia is important, but the condition is often resistant to conventional treatment. Anifrolumab (ANI), a novel therapeutic agent for SLE that inhibits type I interferon activity, has been shown to be effective against acute skin lesions, including alopecia, in patients with SLE...
April 10, 2024: Modern rheumatology case reports
https://read.qxmd.com/read/38592995/clinical-and-laboratory-assessment-of-the-state-of-periapical-tissues-in-systemic-lupus-erythematosus
#11
JOURNAL ARTICLE
Ivan Luchyn, Svyatoslav Zhero, Andrej Jenča, Andrej Jenča, Adriana Petrašova, Janka Jenčova
OBJECTIVE: Aim: To evaluate changes in clinical and laboratory parameters in patients with SLE depending on the severity and activity of the disease. PATIENTS AND METHODS: Materials and Methods: The study included 50 patients with SLE of different age groups, 10 men and 40 women. RESULTS: Results: Systemic lupus erythematosus (SLE) is a chronic disease that belongs to the group of rheumatic diseases and is characterised by autoimmune tissue damage...
2024: Wiadomości Lekarskie: Organ Polskiego Towarzystwa Lekarskiego
https://read.qxmd.com/read/38587826/systemic-lupus-erythematosus-a-review
#12
JOURNAL ARTICLE
Caroline H Siegel, Lisa R Sammaritano
IMPORTANCE: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by inflammation and immune-mediated injury to multiple organ systems, including the mucocutaneous, musculoskeletal, hematologic, and kidney systems. Approximately 3.4 million people worldwide have received a diagnosis of SLE. OBSERVATIONS: Approximately 90% of people with SLE are female. Although there are no uniformly accepted diagnostic criteria for SLE, the 2019 European Alliance of Associations for Rheumatology (formerly the European League Against Rheumatism)/American College of Rheumatology classification criteria developed for scientific study are an estimated 96...
April 8, 2024: JAMA
https://read.qxmd.com/read/38587355/enrolment-of-the-first-paediatric-cohort-into-the-australian-lupus-registry-and-biobank-a-single-centre-experience
#13
JOURNAL ARTICLE
Bronwyn D Power, Rangi Kandane-Rathnayake, Georgina Tiller, William D Renton, Angela Cox, Lilian Johnstone, Alberta Hoi, Peter Gowdie
INTRODUCTION: We aim to report on the feasibility of establishment of the first paediatric cohort as part of the longitudinal database of the Australian Lupus Registry and Biobank (ALRB) and to describe the enrolment data with a focus on clinical characteristics, serological data, treatment strategies and patient/parent-reported outcome measures. METHODS: All patients under the age of 18 years with a diagnosis of systemic lupus erythematosus (SLE) attending the paediatric rheumatology service of a single, tertiary hospital were identified...
April 8, 2024: Lupus
https://read.qxmd.com/read/38586478/maternal-fetal-outcomes-in-patients-with-immune-mediated-inflammatory-diseases-with-consideration-of-comorbidities-a-retrospective-cohort-study-in-a-large-u-s-healthcare-system
#14
JOURNAL ARTICLE
Yeon Mi Hwang, Qi Wei, Samantha N Piekos, Bhargav Vemuri, Sevda Molani, Philip Mease, Leroy Hood, Jennifer Hadlock
BACKGROUND: Immune-mediated inflammatory diseases (IMIDs) are likely to complicate maternal health. However, literature on patients with IMIDs undergoing pregnancy is scarce and often overlooks the presence of comorbidities. We aimed to evaluate the impact of IMIDs on adverse pregnancy outcomes after assessing and addressing any discrepancies in the distribution of covariates associated with adverse pregnancy outcomes between patients with and without IMIDs. METHODS: We conducted a retrospective cohort study using data from an integrated U...
February 2024: EClinicalMedicine
https://read.qxmd.com/read/38576947/a-30-year-old-female-with-dermatomyositis-without-high-elevation-of-muscle-enzymes-a-rare-case-report-from-syria
#15
Suaad Hamsho, Bilal Sleiay, Mouhammed Sleiay, Obeda Batrash, Hadi Alabdullah, Majed Aboud
INTRODUCTION AND IMPORTANCE: Dermatomyositis (DM), sometimes referred to as inflammatory and degenerative changes in the skin and muscles, is a rare autoimmune disorder. DM is distinguished by myopathic disease, symmetrical proximal muscle weakness, and increased creatine kinase (CK). CASE PRESENTATION: A 30-year-old-female presented to the department of dermatology with a history of chronic right hand pain spreading to the shoulder, severe tachycardia, and dyspenia that increased during routine tasks like using the bathroom...
April 2024: Annals of Medicine and Surgery
https://read.qxmd.com/read/38572016/systemic-disease-presenting-as-cardiac-tamponade-a-case-report
#16
Maria Inês Barradas, Inês Coutinho Dos Santos, Fabiana Duarte, Anabela Tavares, Dinis Martins
BACKGROUND: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by multisystem inflammation and is a common cause of pericarditis and pericardial effusion, but significant pericardial effusion and cardiac tamponade are rare and even rarer as the first manifestation. CASE SUMMARY: We report the case of a young male who presented with fever, recurrent pericarditis, and polyserositis with pericardial and bilateral pleural effusion. On examination, he was haemodynamically unstable and the pericardial effusion had considerable dimensions and an urgent pericardiocentesis was performed...
April 2024: European Heart Journal. Case Reports
https://read.qxmd.com/read/38558805/novel-and-potential-future-therapeutic-options-in-systemic-autoimmune-diseases
#17
REVIEW
Lili Balogh, Katalin Oláh, Soma Sánta, Nóra Majerhoffer, Tamás Németh
Autoimmune inflammation is caused by the loss of tolerance to specific self-antigens and can result in organ-specific or systemic disorders. Systemic autoimmune diseases affect a significant portion of the population with an increasing rate of incidence, which means that is essential to have effective therapies to control these chronic disorders. Unfortunately, several patients with systemic autoimmune diseases do not respond at all or just partially respond to available conventional synthetic disease-modifying antirheumatic drugs and targeted therapies...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38550902/fever-of-unknown-origin-in-pregnancy-a-case-report
#18
Gail Ohaegbulam, Laura E Coats, Miller Carlton, Sarah Araji
Systemic lupus erythematosus is an autoimmune disease that primarily affects women of reproductive age. In pregnancy, it can lead to maternal and fetal complications. However, diagnosis in pregnancy is challenging since the disease mimics many features associated with other disorders and some complications related to pregnancy. Here we report a 24-year-old woman at 26 weeks gestation who presented with a fever of unknown origin. She developed tachycardia, nausea, fatigue, rigors, and pancytopenia. Once sepsis and other chronic conditions were ruled out, rheumatology was consulted...
March 2024: Case Reports in Women's Health
https://read.qxmd.com/read/38550246/necrotizing-parasagittal-meningioma-in-patient-with-systemic-lupus-erythematosus-after-treatments-with-methotrexate-and-hydroxychloroquine
#19
Thitikan Wangapakul, Ambar Elizabeth Riley Moguel, Abdel Raouf Kayssi
Objective  Meningiomas are the most common extra-axial tumors of the central nervous system. Meningiomas are particularly problematic when they invade deep or vital structures, causing the tumors to be inoperable. Nonsurgical adjunctive or salvage treatments to shrink a meningioma with multiple recurrences, located in deep-seated area or surgically unfit area, remain underexplored. The authors report a rare case of a spontaneously necrotic meningioma (World Health Organization [WHO] grade I) in a patient with systemic lupus erythematosus on chronic methotrexate and hydroxychloroquine...
January 2024: Journal of Neurological Surgery Reports
https://read.qxmd.com/read/38540223/serum-advanced-glycation-end-products-and-their-soluble-receptor-as-new-biomarkers-in-systemic-lupus-erythematosus
#20
JOURNAL ARTICLE
Irene Carrión-Barberà, Laura Triginer, Laura Tío, Carolina Pérez-García, Anna Ribes, Victoria Abad, Ana Pros, Jordi Monfort, Tarek Carlos Salman-Monte
It has been postulated that advanced glycation end products (AGEs) and their soluble receptor (sRAGE) may play a relevant role as inducers in the chronic inflammatory pathway in various conditions, among them, in immune-mediated diseases such as systemic lupus erythematosus (SLE). However, previous studies show conflicting results about their association with SLE characteristics and their usefulness as disease biomarkers. We aimed to study the association of specific serum AGEs (pentosidine, Nξ-(carboxymethyl)lysine (CML), Nξ-(carboxyethyl)lysine (CEL)), sRAGE levels and AGEs (specific serum AGEs and skin AGEs) to sRAGE ratios with various disease parameters, in order to clarify their potential as new biomarkers in SLE and to study their relationship with cardiovascular disease (CVD)...
March 7, 2024: Biomedicines
keyword
keyword
63236
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.